Kiromic BioPharma Inc. (KRBP)
OTC: KRBP
· Real-Time Price · USD
0.20
0.00 (0.05%)
At close: Mar 24, 2025, 3:59 PM
Kiromic BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.14M | 2.92M | 4.18M | 3.68M | 3.2M | 4.38M | 2.7M | 2.05M | 645.2K | 432.7K | 6.51M | 15.12M | 25.35M | 35.16M | 3.07M | 7.34M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 21K | 21K | 21K | 21K | 21.4K | 21.4K | 21.4K | 24.4K | 24.4K | 31.1K | 31.1K | 31.1K | 31.1K | 31.2K | 24.4K | 24.4K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.2K | 5.8K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.16M | 1.38M | 1.98M | 1.89M | 1.23M | 1.56M | 2.01M | 1.46M | 1.04M | 1.71M | 1.52M | 1.61M | 1.7M | 750.5K | 875.6K | 513.5K |
Total Current Assets | 3.3M | 4.3M | 6.03M | 5.57M | 4.43M | 5.94M | 4.71M | 3.52M | 1.69M | 2.14M | 8.03M | 16.73M | 27.07M | 35.92M | 3.95M | 7.85M |
Property-Plant & Equipment | 5.22M | 5.92M | 6.42M | 7.04M | 7.72M | 8.27M | 8.9M | 9.57M | 10.25M | 10.85M | 11.46M | 9.13M | 3.63M | 2.58M | 2.47M | 2.28M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 427.8K | n/a | n/a |
Total Long-Term Assets | 5.24M | 5.94M | 6.44M | 7.06M | 7.74M | 8.3M | 8.92M | 9.59M | 10.28M | 10.88M | 11.49M | 9.16M | 3.66M | 3.04M | 2.49M | 2.3M |
Total Assets | 8.54M | 10.24M | 12.46M | 12.63M | 12.17M | 14.23M | 13.64M | 13.11M | 11.97M | 13.02M | 19.52M | 25.89M | 30.73M | 38.96M | 6.44M | 10.15M |
Account Payables | 2.68M | 1.69M | 2M | 2M | 2.14M | 4.25M | 6.62M | 8.15M | 7.31M | 6.49M | 4.16M | 2.3M | 2.21M | 927.7K | 1.12M | 1.2M |
Deferred Revenue | n/a | n/a | n/a | -12.19M | n/a | n/a | -227.6K | n/a | n/a | n/a | n/a | n/a | -454.5K | n/a | n/a | n/a |
Short-Term Debt | 13.65M | 670K | 12.14M | 12.19M | 14M | 9.66M | 8.26M | 9.98M | 4.37M | 547.8K | 114.9K | 285.7K | 454.5K | n/a | 91.6K | 227.8K |
Other Current Liabilities | 1.78M | 16.77M | 1.33M | 3.31M | 2.75M | 2.52M | 2.99M | 491.3K | 355K | 3.05M | 650.5K | 742.9K | 467.1K | 385.7K | 294.5K | 173.9K |
Total Current Liabilities | 20.9M | 19.13M | 17.06M | 19.09M | 20.38M | 17.65M | 18.7M | 19.86M | 13.28M | 11.11M | 5.97M | 4.11M | 3.41M | 1.44M | 1.57M | 1.7M |
Long-Term Debt | n/a | 14.04M | n/a | n/a | n/a | n/a | n/a | n/a | 2.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | -404K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.5K | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 228K | 14.04M | 577K | 747K | 911.5K | 1.07M | 1.23M | 1.39M | 4.46M | 1.63M | 1.77M | 1.75M | 2.21M | n/a | n/a | n/a |
Total Liabilities | 21.13M | 19.53M | 17.63M | 19.84M | 21.29M | 18.72M | 19.93M | 21.25M | 17.74M | 12.74M | 7.74M | 5.86M | 3.41M | 1.44M | 1.57M | 1.7M |
Total Debt | 14.57M | 14.71M | 13.37M | 13.58M | 15.54M | 11.35M | 10.1M | 11.97M | 9.41M | 2.17M | 2.42M | 2.51M | 454.5K | n/a | 91.6K | 227.8K |
Common Stock | 2K | 1K | 1K | 1K | 1.26K | 1.18K | 1.18K | 979.00 | 648.00 | 9.3K | 9.3K | 9.3K | 9.3K | 9.3K | 1.3K | 1.2K |
Retained Earnings | -149.79M | -143.3M | -135.87M | -129.04M | -122.9M | -118.21M | -114.01M | -107.25M | -101.95M | -94.88M | -83.02M | -74.58M | -67.22M | -56.58M | -50.46M | -45.48M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -657.3K |
Shareholders Equity | -12.59M | -9.29M | -5.17M | -7.21M | -9.12M | -4.49M | -6.29M | -8.14M | -5.77M | 284.1K | 11.78M | 20.03M | 27.32M | 37.51M | 4.87M | 8.45M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |